When Taylor Warmoth, MD, a rheumatologist with Arthritis and Osteoporosis Associates (AOA), Lubbock, Texas, posted her first educational video on TikTok in 2022, she anticipated a moderate response. She was surprised when her medical assistant informed her the next day that her video had received over 5,000 views, 800 comments, and her account had gained…
Search results for: fatigue
Findings from a Clinical Trial of Dazodalibep for Sjögren’s Disease
St.Clair et al. found that patients with Sjögren’s disease treated with dazodalibep experienced greater improvement in key symptoms of dryness, fatigue and pain than patients who received placebo.
Guideline for Integrative RA Interventions Released
Discussions between clinicians and their patients about complementary aspects of their care just got easier with the release of the 2022 ACR Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis.
Patient Education Materials for Non-English Speakers
Recently, the Vasculitis Foundation, in collaboration with a group of physicians and vasculitis investigators in the U.S. and Latin America (i.e., Mexico, Colombia, Peru, Chile and Argentina), launched an educational series of videos in Spanish called, Aprendiendo de Vasculitis. “The goal of these videos is to provide education to all Spanish-speaking patients,” explains Sebastian E….
Break the Barrier: Understanding & Treating Neuropsychiatric Lupus
Updated research on the complexities of central nervous system (CNS) lupus, as well as its diagnosis and treatment are discussed.
Mixed Results for Rezpegaldesleukin in Patients with Active SLE
In a clinical trial, patients with active systemic lupus erythematosus (SLE) did not experience a reduction in disease activity with the addition of rezpegaldesleukin to their standard treatments. However, some patient populations did see improvements in their disease activity compared with the placebo-treated group.
RA Disease Activity & Alcohol Consumption Habits
Past studies have suggested that patients with rheumatoid arthritis (RA) who consume a moderate amount of alcohol may experience lower disease activity and higher quality of life than non-drinkers. In this study, Alfredsson, et al. confirmed earlier studies’ claims that alcohol consumption reduces disease activity in a dose-dependent manner, and also indicated that patients who stopped drinking post-baseline experienced worsened disease activity, more pain and a lower quality of life.
Letter to the Editor: A Workforce Shortage Solution
The issue of the rheumatology workforce shortage is certainly vexing. Not only does it leave large segments of the population without adequate care for patients with serious rheumatic diseases, but it also increases the burden on the few rheumatologists who serve populous, underserved regions of the country. Solutions suggested in The Rheumatologist (“ACR Workforce Solutions…
Case Report: Migratory Polyarthritis as the Presenting Symptom of GPA
Granulomatosis with polyangiitis (GPA) is a primary, necrotizing granulomatous vasculitis, involving small- to medium-sized arteries, that causes systemic disease. Almost any organ can be affected, but the most affected systems are the upper airways, lungs, kidneys, eyes and peripheral nerves. Migratory polyarthritis is reported in approximately 25% of patients with anti-neutrophil cytoplasmic antibody (ANCA) associated…
Psoriatic Arthritis Drugs at a Glance, 2023
Biosimilars have become a therapeutic turning point for many patients who are living with rheumatic illnesses. Psoriatic arthritis (PsA) is a complex, multi-faceted chronic inflammatory musculoskeletal and skin disease where the treatment has changed considerably over the past few years. Psoriatic arthritis has an impact on about 30% of people with psoriasis.1 In 2019, the…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 58
- Next Page »